Financial & ESG Information

Financial Highlights

Statistics and graphs of financial information for the last 5 years.

Click here for financial information for the last 11 years.(PDF & Excel data)

Operating Results

Operating Results (Graph)

Operating Results

Years Ended March 31 2021 2022 2023 2024 2025
¥B % ¥B % ¥B % ¥B % ¥B %
Revenue 1,630.2 100.0 1,812.5 100.0 1,686.8 100.0 1,640.2 100.0 1,743.4 100.0
Operating profit 313.2 19.2 424.1 23.4 297.9 17.7 215.4 13.1 279.7 16.0
Profit before tax 316.4 19.4 432.7 23.9 314.9 18.7 239.4 14.6 304.4 17.5
Profit attributable to owners of parent 237.1 14.5 314.1 17.3 253.7 15.0 180.8 11.0 233.8 13.4

Regarding revenue during the period, revenue of SAW filters and connectivity modules decreased for smartphones. However, revenue of capacitors (MLCCs) increased for computers and mobility. Additionally, revenue of multilayer resin substrates and inductors increased for smartphones. As a result, revenue increased by 6.3% year on year to 1,743.4 billion yen, boosted in part by foreign currency fluctuations (the yen depreciated by 7.95 yen year on year).
Looking at profits, operating profit was 279.7 billion yen, up 29.8% year on year, profit before tax was 304.4 billion yen, up 27.2% year on year, and profit attributable to owners of parent came to 233.8 billion yen, up 29.3% year on year. This was due to profit-increasing factors such as an increase in the operation rate and a cost reduction despite profit-decreasing factors such as a fall in product selling prices and an increase in fixed costs.

Financial Indices

ROE, ROA, ROIC[pre-tax basis] (Graph)

Financial Indices

Years Ended March 31/
As of March 31
2021 2022 2023 2024 2025
Total Assets (¥B) 2,462.3 2,809.2 2,872.8 3,037.9 3,028.2
Asset Turnover (Times)
Net Sales/Average Total Assets
0.69 0.69 0.59 0.55 0.57
Shareholders' Equity (¥B) 1,920.8 2,263.6 2,402.5 2,556.1 2,580.8
Shareholders' Equity Ratio (%)
Shareholders' Equity/Total Assets
78.0 80.6 83.6 84.1 85.2
Return on Equity (ROE) (%)
Net Income/Average Shareholders' Equity
13.1 15.0 10.9 7.4 9.1
Return on Assets (ROA) (%)
Income before Income Taxes/
Average Total Assets
13.4 16.4 11.1 8.1 10.0
Return on Invested Capital
(ROIC[pre-tax basis]) (%)
Pre-tax operating income / Average invested capital at the beginning and end of the period (=Net fixed assets[book value]+inventories+accounts receivable-trade-accounts payable-trade )
18.5 22.6 14.6 10.0 13.0

Total assets at the end of the period decreased by 97.0 billion yen from the end of the previous fiscal year to 3,028.2 billion yen primarily due to decreases in inventories and other non-current asset, despite increases in other financial assets and deferred tax assets. Total liabilities decreased by 34.1 billion yen from the end of the previous fiscal year to 448.2 billion yen mainly due to a decrease in bonds and borrowings and other financial liabilities. Total equity increased by 24.4 billion yen from the end of the previous fiscal year to 2,580.0 billion yen , primarily due to increases in retained earnings, despite decreases in capital surplus and other components of equity. The ratio of equity attributable to owners of parent up by 1.1 points from the end of the previous fiscal year to 85.2%.
Return on invested capital (ROIC) (pre-tax basis) during the period was 13.0%, a year-on-year increase of 3.0 percentage points, due to the significant increase in operating profit, in addition to a decrease in invested capital, including inventory.

Capex, Depreciation and Amortization, R&D Expenses

Capital Expenditures (Graph)

Depreciation and Amortization, Ratio of Depreciation and Amortization to Net Sales (Graph)

R&D Expenses, Ratio of R&D Expenses to Net Sales(Graph)

Capex, Depreciation and Amortization, R&D Expenses

Years Ended March 31 2021 2022 2023 2024 2025
Capital Expenditures (¥B) 196.7 152.8 208.1 219.5 180.5
Depreciation and Amortization (¥B) 143.1 155.6 161.3 175.9 173.3
Ratio of Depreciation and Amortization to Revenue (%) 8.8 8.6 9.6 10.7 9.9
R&D Expenses (¥B) 101.7 111.3 124.2 132.5 149.3
Ratio of R&D Expenses to Revenue (%) 6.2 6.1 7.4 8.1 8.6